Global Medicinal Grade Cannabis Market Growth 2023-2029

Global Medicinal Grade Cannabis Market Growth 2023-2029

Cannabis is a drug made from the cannabis plant, which is considered a medical drug in countries where it is legalized. It is made by drying the flowers and trichomes of female marijuana. It is mainly divided into three cultivars of common cannabis Indian cannabis and hybrid cannabis that combine the characteristics of the two. Its main effect is on the mental side, the main ingredient is THC, and cannabis also contains more than 423 known compounds, including at least 65 other cannabinoids, such as cannabidiol, cannabidiol, and their sensory effects There is a clear difference in the psychoactive effects produced by THC. The term Marijuana refers to cannabis in herbal form, including mature female flowers, leaves, and stems, while Hashish refers to cannabis resin, a way of concentrating cannabis.

LPI (LP Information)' newest research report, the “Medicinal Grade Cannabis Industry Forecast” looks at past sales and reviews total world Medicinal Grade Cannabis sales in 2022, providing a comprehensive analysis by region and market sector of projected Medicinal Grade Cannabis sales for 2023 through 2029. With Medicinal Grade Cannabis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medicinal Grade Cannabis industry.

This Insight Report provides a comprehensive analysis of the global Medicinal Grade Cannabis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medicinal Grade Cannabis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Medicinal Grade Cannabis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medicinal Grade Cannabis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medicinal Grade Cannabis.

The global Medicinal Grade Cannabis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Medicinal Grade Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Medicinal Grade Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Medicinal Grade Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Medicinal Grade Cannabis players cover Ultra Health, Mammoth Farms, Palo Verde Center, Hexo Corp, Bright Green Corporation, Copperstate Farms, Los Suenos Farms, Canna and Village Farms, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Medicinal Grade Cannabis market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Dronabinol
Nabilone
Nabiximols
Cannabidiol
Other

Segmentation by application
Hospital
Clinic
Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ultra Health
Mammoth Farms
Palo Verde Center
Hexo Corp
Bright Green Corporation
Copperstate Farms
Los Suenos Farms
Canna
Village Farms
Aurora
Canopy Growth
Cresco Labs
Glass House Farms
Organigram
C3 International
CannTrust
FlowerOne
Solaris Farms
7Acres
ThePharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medicinal Grade Cannabis market?

What factors are driving Medicinal Grade Cannabis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medicinal Grade Cannabis market opportunities vary by end market size?

How does Medicinal Grade Cannabis break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.